575456-24-5

Upstream product

• 105-13-5 4-Methoxybenzyl alcohol 
• 381665-45-8 (6R)-6-{(1E,3R,4R,6R,7Z,9Z,11E)-6-{[tert-butyl(dimethyl)silyl]oxy}-13-{[tert-butyl(diphenyl)silyl]oxy}-4-hydroxy-3-methyl-3-[(triethylsilyl)oxy]trideca-1,7,9,11-tetraen-1-yl}-5,6-dihydro-2H-pyran-2-one 
• 445235-62-1 (2E,5R)-1-benzoyloxy-5,6-isopropylidenedioxy-2-methyl-2-hexene 
• 445235-60-9 methyl (2E,5R)-5,6-isopropylidenedioxy-2-methyl-2-hexenoate 
• 445235-61-0 (2E,5R)-5,6-isopropylidenedioxy-2-methyl-2-hexen-1-ol 
• 445235-78-9 (6R,1'E,3'R,4'R,6'R,7'Z)-6-[6'-tert-butyldimethylsiloxy-8'-iodo-3'-methyl-3',4'-bis(triethylsiloxy)-1',7'-octadienyl]-5,6-dihydro-2H-pyran-2-one 

Downstream Products

• 87810-56-8 (+)-fostriecin 

Relevant academic research and scientific papers

Total synthesis of an antitumor antibiotic, fostriecin (CI-920)

The total synthesis of an antitumor antibiotic, fostriecin (CI-920), via a highly convergent route is described. A characteristic feature of the present total synthesis is that the synthesis was achieved via a coupling procedure of three segments A, B, an

Total synthesis of fostriecin (CI-920) via a convergent route

Fostriecin, a potent and promising antitumor antibiotic, was stereoselectively synthesized via a convergent route involving a three-segement coupling procedure.